1887

Abstract

An efficient antigen expression system using a recombinant Sendai virus (SeV) has been established recently and its potential to induce resistance against immunodeficiency virus infections in macaques has been shown. SeV replication has been well characterized in mice, the natural host, but not in primates, including humans. Here, primary SeV replication was investigated in macaques. After intranasal immunization with a recombinant SeV expressing simian immunodeficiency virus Gag protein, SeV-Gag, robust expression was observed in the nasal mucosa and much lower but significant levels of expression were observed in the local retropharyngeal and submandibular lymph nodes (LN). Expression peaked within a week and lasted at least up to 13 days after immunization. SeV-Gag was isolated from nasal swabs consistently at day 4 but not at all at day 13. expression was undetectable in the lung as well as in remote lymphoid tissues, such as the thymus, spleen and inguinal LN, indicating that the spread of the virus was more restricted in macaques than in mice. SeV-specific T cells were detectable in SeV-immunized macaques at day 7. Finally, no naive macaques showed significant levels of anti-SeV antibodies in the plasma, even after living in a cage together with an acutely SeV-infected macaque for 5 weeks, indicating that SeV transmission from SeV-infected macaques to naive ones was inefficient. None of the SeV-immunized macaques displayed appreciable clinical manifestations. These results support the idea that this system may be used safely in primates, including humans.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-6-1377
2002-06-01
2019-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/6/0831377a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-6-1377&mimeType=html&fmt=ahah

References

  1. Akaike, T., Fujii, S., Kato, A., Yoshitake, J., Miyamoto, Y., Sawa, T., Okamoto, S., Suga, M., Asakawa, M., Nagai, Y. & Maeda, H. ( 2000; ). Viral mutation accelerated by nitric oxide production during infection in vivo. FASEB Journal 14, 1447-1454.[CrossRef]
    [Google Scholar]
  2. Brander, C. & Walker, B. D. ( 1999; ). T lymphocyte responses in HIV-1 infection: implications for vaccine development. Current Opinion in Immunology 11, 451-459.[CrossRef]
    [Google Scholar]
  3. Butz, E. A. & Bevan, M. J. ( 1998; ). Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8, 167-175.[CrossRef]
    [Google Scholar]
  4. Donahoe, S. M., Moretto, W. J., Samuel, R. V., Metzner, K. J., Marx, P. A., Hanke, T., Connor, R. I. & Nixon, D. F. ( 2000; ). Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus. Virology 272, 347-356.[CrossRef]
    [Google Scholar]
  5. Gea-Banacloche, J. C., Migueles, S. A., Martino, L., Shupert, W. L., McNeil, A. C., Sabbaghian, M. S., Ehler, L., Prussin, C., Stevens, R., Lambert, L., Altman, J., Hallahan, C. W., de Quiros, J. C. & Connors, M. ( 2000; ). Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. Journal of Immunology 165, 1082-1092.[CrossRef]
    [Google Scholar]
  6. Hasan, M. K., Kato, A., Shioda, T., Sakai, Y., Yu, D. & Nagai, Y. ( 1997; ). Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3’ proximal first locus. Journal of General Virology 78, 2813-2820.
    [Google Scholar]
  7. Hurwitz, J. L., Soike, K. F., Sangster, M. Y., Portner, A., Sealy, R. E., Dawson, D. H. & Coleclough, C. ( 1997; ). Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15, 533-540.[CrossRef]
    [Google Scholar]
  8. Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., Kostrikis, L. G., Zhang, L., Perelson, A. S. & Ho, D. D. ( 1999; ). Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. Journal of Experimental Medicine 189, 991-998.[CrossRef]
    [Google Scholar]
  9. Kano, M., Matano, T., Nakamura, H., Takeda, A., Kato, A., Ariyoshi, K., Mori, K., Sata, T. & Nagai, Y. ( 2000; ). Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein. AIDS 14, 1281-1282.[CrossRef]
    [Google Scholar]
  10. Kato, A., Sakai, Y., Shioda, T., Kondo, T., Nakanishi, M. & Nagai, Y. ( 1996; ). Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes to Cells 1, 569-579.[CrossRef]
    [Google Scholar]
  11. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T. & Nagai, Y. ( 1997a; ). The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO Journal 16, 578-587.[CrossRef]
    [Google Scholar]
  12. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., Shioda, T. & Nagai, Y. ( 1997b; ). Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. Journal of Virology 71, 7266-7272.
    [Google Scholar]
  13. Kato, A., Ohnishi, Y., Kohase, M., Saito, S., Tashiro, M. & Nagai, Y. ( 2001; ). Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. Journal of Virology 75, 3802-3810.[CrossRef]
    [Google Scholar]
  14. Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., Regier, D., Sehgal, P., Daniel, M., King, N. & Desrosiers, R. ( 1990; ). Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109-1112.[CrossRef]
    [Google Scholar]
  15. Kiyotani, K., Takao, S., Sakaguchi, T. & Yoshida, T. ( 1990; ). Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology 177, 65-74.[CrossRef]
    [Google Scholar]
  16. Lavini, A., Brookes, R., Hambleton, S., Britton, W. J., Hill, A. V. & McMichael, A. J. ( 1997; ). Rapid effector function in CD8+ memory T cells. Journal of Experimental Medicine 186, 859-865.[CrossRef]
    [Google Scholar]
  17. Li, H. O., Zhu, Y. F., Asakawa, M., Kuma, H., Hirata, T., Ueda, Y., Lee, Y. S., Fukumura, M., Iida, A., Kato, A., Nagai, Y. & Hasegawa, M. ( 2000; ). A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. Journal of Virology 74, 6564-6569.[CrossRef]
    [Google Scholar]
  18. Mackett, M., Smith, G. L. & Moss, B. ( 1982; ). Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, USA 79, 7415-7419.[CrossRef]
    [Google Scholar]
  19. Matano, T., Odawara, T., Ohshima, M., Yoshikura, H. & Iwamoto, A. ( 1993; ). Trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus. Journal of Virology 67, 2026-2033.
    [Google Scholar]
  20. Matano, T., Shibata, R., Siemon, C., Connors, M., Lane, H. C. & Martin, M. A. ( 1998; ). Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. Journal of Virology 72, 164-169.
    [Google Scholar]
  21. Matano, T., Kano, M., Odawara, T., Nakamura, H., Takeda, A., Mori, K., Sato, T. & Nagai, Y. ( 2000; ). Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus. Vaccine 18, 3310-3318.[CrossRef]
    [Google Scholar]
  22. Matano, T., Kano, M., Nakamura, H., Takeda, A. & Nagai, Y. ( 2001; ). Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai viral vector boost regimen. Journal of Virology 75, 11891-11896.[CrossRef]
    [Google Scholar]
  23. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. & Ahmed, R. ( 1998; ). Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187.[CrossRef]
    [Google Scholar]
  24. Nagai, Y. ( 1993; ). Protease-dependent virus tropism and pathogenicity. Trends in Microbiology 1, 81-87.[CrossRef]
    [Google Scholar]
  25. Nagai, Y. ( 1999; ). Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Reviews in Medical Virology 9, 83-99.[CrossRef]
    [Google Scholar]
  26. Nagai, Y. & Kato, A. ( 1999; ). Paramyxovirus reverse genetics is coming of age. Microbiology and Immunology 43, 613-624.[CrossRef]
    [Google Scholar]
  27. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., Hurley, A., Markowitz, M., Ho, D. D., Nixon, D. F. & McMichael, A. J. ( 1998; ). Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106.[CrossRef]
    [Google Scholar]
  28. Rowland-Jones, S. L., Dong, T., Fowke, K. R., Kimani, J., Krausa, P., Newell, H., Blanchard, T., Ariyoshi, K., Oyugi, J., Ngugi, E., Bwayo, J., MacDonald, K. S., McMichael, A. J. & Plummer, F. A. ( 1998; ). Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. Journal of Clinical Investigation 102, 1758-1765.[CrossRef]
    [Google Scholar]
  29. Sakai, Y., Kiyotani, K., Fukumura, M., Asakawa, M., Kato, A., Shioda, T., Yoshida, T., Tanaka, A., Hasegawa, M. & Nagai, Y. ( 1999; ). Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Letters 456, 221-226.[CrossRef]
    [Google Scholar]
  30. Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., Ghrayeb, J., Forman, M. A., Montefiori, D. C., Rieber, E. P., Letvin, N. L. & Reimann, K. A. ( 1999; ). Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857-860.[CrossRef]
    [Google Scholar]
  31. Seder, R. A. & Hill, A. V. S. ( 2000; ). Vaccines against intracellular infections requiring cellular immunity. Nature 406, 793-798.[CrossRef]
    [Google Scholar]
  32. Shibata, R., Maldarelli, F., Siemon, C., Matano, T., Parta, M., Miller, G., Fredrickson, T. & Martin, M. A. ( 1997; ). Infection and pathogenicity of chimeric simian–human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. Journal of Infectious Diseases 176, 362-373.[CrossRef]
    [Google Scholar]
  33. Suen, J. Y. & Stern, S. J. ( 1996; ). Cancer of the Neck. In Cancer of the Head and Neck , pp. 462-484. Edited by E. N. Myers & J. Y. Suen. Philadelphia: W. B. Saunders.
  34. Voss, G., Nick, S., Stahl-Hennig, C., Ritter, K. & Hunsmann, G. ( 1992; ). Generation of macaque B lymphoblastoid cell lines with simian Epstein–Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. Journal of Virological Methods 39, 185-195.[CrossRef]
    [Google Scholar]
  35. Watanabe, T., Nakamura, K., Wakugawa, M., Kato, A., Nagai, Y., Shioda, T., Iwamoto, A. & Tamaki, K. ( 2000; ). Antibodies to molluscum contagiosum virus in the general population and susceptible patients. Archives of Dermatology 136, 1518-1522.
    [Google Scholar]
  36. Yonemitsu, Y., Kitson, C., Ferrari, S., Farley, R., Griesenbach, U., Judd, D., Steel, R., Scheid, P., Zhu, J., Jeffery, P. K., Kato, A., Hasan, M. K., Nagai, Y., Masaki, I., Fukumura, M., Hasegawa, M., Geddes, D. M. & Alton, E. W. F. W. ( 2000; ). Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nature Biotechnology 18, 970-973.[CrossRef]
    [Google Scholar]
  37. Yu, D., Shioda, T., Kato, A., Hasan, M. K., Sakai, Y. & Nagai, Y. ( 1997; ). Sendai virus-based expression of HIV-1 gp120: reinforcement by the V version. Genes to Cells 2, 457-466.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-6-1377
Loading
/content/journal/jgv/10.1099/0022-1317-83-6-1377
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error